drugset / Trial / NCT03265470

Renal Protection of Intravenous Dexmedetomidine During Radical Cystectomy

NCT03265470 ↗

Completed 100 enrolled Mansoura University
RandomizedParallel-groupSingle-blindSupportive care

Summary

Acute kidney injury and chronic kidney disease usually associated with radical cystectomy operation which is the treatment of choice for invasive urinary bladders tumor. Peri-operative acute kidney injury (AKI) is common but poorly recognized and managed which is associated with increase surgical morbidity and mortality and hospital cost .Prospective human studies establishing a renal protective effect of dexmedetomidine are still questionable.

Timeline

Start
2015-12-01
Primary completion
2020-03-30
Completion
2020-08-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.4 ug/kg Intravenous
Comparator Fentanyl Other / unclassified 1 ug/kg Intravenous

Indications

No indication recorded.